Hims vs JRNYS
Hims and JRNYS sell different medications; this is what separates them.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Hims
Best for: knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC
Visit Hims →
JRNYS
Best for: seeing what it charges before you answer any medical questions
Visit JRNYS →If you are choosing between Hims and JRNYS, price alone will not settle it. Hims leads our six-part score, 6.8 to 5.9. One of the two has an FDA warning letter on record, covered below.
Hims vs JRNYS price
Hims publishes $199 a month. JRNYS does not post a GLP-1 price we can quote, so you would only learn its cost after an intake.
Medications and formats
Hims lists semaglutide and tirzepatide; JRNYS does not name its drug.
On format, Hims prices compounded injections and brand-name pens, while JRNYS posts no priced format.
If you want the FDA-approved brand rather than a compounded version, Hims is the only one of the two with a brand-name price.
Where each one treats patients
Hims lists 50 states, and JRNYS does not publish where it ships.
Pricing
Hims
Brand Zepbound from $299/mo medication-only; requires Hims Weight Loss Membership ($149/mo)
JRNYS
What each price covers
Hims' price also covers the medication itself, which JRNYS does not claim.
JRNYS' price also covers the clinician visit, which Hims does not claim.
Hims is silent on shipping and lab work.
JRNYS is silent on shipping, lab work and coaching.
That matters most for the drug: unless JRNYS confirms otherwise, budget for medication on top of its listed price.
Hims
Covered by the monthly price
Medication
In the price
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Not stated
Coaching
Charged on top
JRNYS
Covered by the monthly price
Medication
Charged on top
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Where each one scores higher
Overall, Hims scores 6.8 and JRNYS 5.9 out of 10.
Hims is stronger on effectiveness (10.0 vs 9.0), trust & safety (7.0 vs 6.5), accessibility (10.0 vs 5.0) and support (3.0 vs 2.5).
Value and user experience are within half a point.
Hims
6.8/10
JRNYS
5.9/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent Hims a warning letter dated September 9, 2025 (letter 716567), and it is still open.
JRNYS has no FDA warning letter on record with us.
Features & Coverage
| Feature | Hims | JRNYS |
|---|---|---|
| Starting Price | $199/mo | Not published |
| Features | 2 features | ✓7 features |
| States Available | 50 | Not disclosed |
| Compounded | ✓ Yes | — |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | 1 letter | ✓None |
About Hims
Hims is a major men's telehealth brand. Its weight loss offering is compounded semaglutide on a 6-month plan.
Read our full Hims review →About JRNYS
What you pay for coaching sets the membership: $89 to $169 per month. On top of that, JRNYS states that a member holding commercial insurance should find the GLP-1 itself capped near $25/month once any deductible clears. Self-pay exists, priced only after a provider consult. The drugs are all branded, semaglutide as Ozempic or Wegovy, tirzepatide as Mounjaro or Zepbound, plus dulaglutide and liraglutide as Saxenda, wrapped in 1-on-1 coaching. Dr. Henry Legere is CMO. The company notes the indication for these drugs is diabetes and that weight loss is an off-label use.
Read our full JRNYS review →Pros & Cons
Hims
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication
- Serves all 50 states
- Names 4 pharmacies that fill its prescriptions, which most sellers do not
Watch-outs
- Not included in the monthly price: clinician visits, coaching
- The FDA has issued Hims a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
JRNYS
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes clinician visits
- We found no FDA warning letters issued to JRNYS
Watch-outs
- Not included in the monthly price: medication
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Our Verdict
Hims wins this one, 6.8 to 5.9, above all for knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC. JRNYS fits better if seeing what it charges before you answer any medical questions is your priority.
Choose Hims if…
You want knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC and an opening price near $199 a month.
Choose JRNYS if…
You want seeing what it charges before you answer any medical questions.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Trimi Health
Knowing which pharmacy fills the vial: it names VialsRx
From $99/mo
Get started →ShedRx
Oral orforglipron alongside the injectables
From $149/mo
Get started →bmiMD
Starting below a standard dose, with microdose tiers
From $99/mo
Get started →Hims vs JRNYS: FAQ
Close alternatives to Hims and JRNYS
- Hims vs Hers
- Hims vs Care Bare Rx
- Hims vs Concierge MD LA
- Hims vs Corsica Health
- JRNYS vs Embody
- JRNYS vs TrimRx
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.